" /> Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140203 - CISMeF





Preferred Label : Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140203;

NCIt definition : A preparation of autologous T-lymphocytes that have been transduced with a lentiviral vector to express a T-cell receptor mimetic (TCRm) construct targeting the immunogenetic human tumor-associated antigen (TAA) alpha-fetoprotein (AFP) complexed with human leukocyte antigen (HLA)-A*02 (HLA-A*02/AFP), with potential immunomodulatory and antineoplastic activities. Upon administration, autologous anti-HLA-A*02/AFP TCRm-expressing T-cells ET140203 specifically recognize and selectively bind to AFP peptides presented by HLA-A*02. This results in cytotoxic T-lymphocyte (CTL)-mediated elimination of AFP-expressing tumor cells. AFP, an intracellularly expressed fetal glycoprotein rarely expressed in adult tissues, is overexpressed in certain tumors of endodermal origin and plays a key role in tumor cell proliferation and survival. AFP is processed into peptides and presented by class I major histocompatibility complexes (MHCs) on the surface of tumor cells.;

Molecule name : ET 140203; ET-140203;

NCI Metathesaurus CUI : CL1412643;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
02/08/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.